Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Press Releases

  • April 28, 2015
    Singulex Key Patent Granted in Japan for Detecting or Monitoring Cardiovascular Disease Using Proprietary Biomarkers
  • April 9, 2015
    Singulex Announces Collaboration with CHDI Foundation to Develop Biomarker Assays for Huntington’s Disease

Upcoming Events

  • Apr 27, 2015 - Apr 28, 2015:
    Next-Gen Biomarker Summit
    Bath, UK
  • Apr 27, 2015 - Apr 28, 2015:
    New Mexico Nurse Practitioner Council Annual Conference
    New Mexico, CA